Metformin ameliorates the mitochondrial damage induced by C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia-related poly-GR

doi:10.3969/j.issn.1674-8115.2023.07.006

Abstract

Abstract:

Objective ·To investigate the effect of C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD)-related poly-glycine-arginine (poly-GR) on mitochondrial morphology and function, and analyze the rescue effect of metformin on mitochondrial damage induced by poly-GR and its underlying mechanism. Methods ·SK-N-SH cells stably overexpressing 50 repeated glycine-arginine sequences [(GR)₅₀] or green fluorescent protein (GFP) were constructed by lentivirus infection, which were respectively named as (GR)₅₀-SK cell line and GFP CTRL-SK cell line. (GR)₅₀ expression in (GR)₅₀-SK cells was verified by Western blotting. GFP expression in GFP GTRL-SK cells was observed by fluorescence microscope. Propidium iodide (PI) staining was used to detect the apoptosis levels of (GR)₅₀-SK and GFP CTRL-SK cells. Immunofluorescence (IF) staining was performed to determine the subcellular location of (GR)₅₀. Reactive oxygen species (ROS) level of mitochondria was evaluated by staining cells with MitoSOX Red followed by observing the intensity of red fluorescence under fluorescence microscope. The mitochondrial morphology of (GR)₅₀-SK and GFP CTRL-SK cells was observed by transmission electron microscopy. Western blotting was used to detect protein kinase B (PKB, also known as AKT) and its phosphorylation levels in (GR)₅₀-SK and GFP CTRL-SK cells. SC79 was used to activate AKT in (GR)₅₀-SK cells, and MitoSOX Red staining and PI staining were used to analyze mitochondrial ROS and apoptosis levels after phosphorylated AKT increased. Metformin was used to treat (GR)₅₀-SK and GFP CTRL-SK cells, respectively, and the apoptosis levels, mitochondrial ROS levels, mitochondrial morphology, AKT and its phosphorylation levels, and ATP concentrations of the two cells were detected by the above methods and ATP detection kit, respectively. Results ·Western blotting showed that the construction of (GR)₅₀-SK cells was successful, and fluorescence microscopy showed that the construction of GFP CTRL-SK cells was also successful. PI staining results showed that the apoptosis level of (GR)₅₀-SK cells was higher than that of the GFP CTRL-SK cells (P=0.016). IF staining results showed that there was partial co-localization of (GR)₅₀ in the mitochondria of (GR)₅₀-SK cells. Compared with GFP CTRL-SK cells, the mitochondrial morphology and structure of (GR)₅₀-SK cells were significant abnormalities, with a significantly increased ROS levels. The AKT levels in (GR)₅₀-SK cells were similar to those in the GFP CTRL-SK cells, but there was a significant decrease in phosphorylated AKT levels. After (GR)₅₀-SK cells were treated with SC79, the AKT phosphorylation level was significantly upregulated, and ROS level and apoptosis level were significantly downregulated. Metformin could significantly up-regulate the phosphorylated AKT levels in (GR)₅₀-SK cells, but had no effect on AKT levels; it could reshape the morphology and structure of some mitochondria, reduce ROS levels, increase ATP production (P=0.000), and down-regulate the level of cell apoptosis (P=0.000). Conclusion ·(GR)₅₀ can cause mitochondrial morphology and function abnormalities by down-regulating AKT phosphorylation, and promote cell apoptosis. Metformin can effectively reduce the occurrence of the above pathological events induced by (GR)₅₀.

Key words: C9ORF72 amyotrophic lateral sclerosis/ frontotemporal dementia (C9ORF72 ALS/FTD), poly-glycine-arginine (poly-GR), mitochondrion, phosphorylated protein kinase B, metformin

CLC Number:

R744.8

FENG Yiyuan, XU Zhongyun, YIN Yafu, WANG Hui, CHENG Weiwei. Metformin ameliorates the mitochondrial damage induced by C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia-related poly-GR[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(7): 839-847.

Figures/Tables 3

TrendMD

References 16

1	GIJSELINCK I, VAN LANGENHOVE T, VAN DER ZEE J, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study[J]. Lancet Neurol, 2012, 11(1): 54-65.
2	KWON I, XIANG S H, KATO M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells[J]. Science, 2014, 345(6201): 1139-1145.
3	TAO Z T, WANG H F, XIA Q, et al. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity[J]. Hum Mol Genet, 2015, 24(9): 2426-2441.
4	SABERI S, STAUFFER J E, JIANG J, et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis[J]. Acta Neuropathol, 2018, 135(3): 459-474.
5	LOPEZ-GONZALEZ R, LU Y B, GENDRON T F, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons[J]. Neuron, 2016, 92(2): 383-391.
6	ZHANG Y J, GENDRON T F, EBBERT M T W, et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis[J]. Nat Med, 2018, 24(8): 1136-1142.
7	LI S, WU Z, TANTRAY I, et al. Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD[J]. Proc Natl Acad Sci USA, 2020, 117(40): 25104-25115.
8	GAYATRI M B, GAJULA N N, CHAVA S, et al. High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis[J]. Cell Death Discov, 2022, 8(1): 277.
9	LESNIK C, GOLANI-ARMON A, ARAVA Y. Localized translation near the mitochondrial outer membrane: an update[J]. RNA Biol, 2015, 12(8): 801-809.
10	CHOI S Y, LOPEZ-GONZALEZ R, KRISHNAN G, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo[J]. Nat Neurosci, 2019, 22(6): 851-862.
11	LI S, WU Z, LI Y, et al. Altered MICOS morphology and mitochondrial ion homeostasis contribute to poly(GR) toxicity associated with C9-ALS/FTD[J]. Cell Rep, 2020, 32(5): 107989.
12	XIE X X, SHU R N, YU C N, et al. Mammalian AKT, the emerging roles on mitochondrial function in diseases[J]. Aging Dis, 2022, 13(1): 157-174.
13	WANG H, CHEN S, ZHANG Y, et al. Electroacupuncture ameliorates neuronal injury by Pink1/Parkin-mediated mitophagy clearance in cerebral ischemia-reperfusion[J]. Nitric Oxide, 2019, 91: 23-34.
14	WANG S, KANDADI M R, REN J. Double knockout of Akt2 and AMPK predisposes cardiac aging without affecting lifespan: role of autophagy and mitophagy[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(7): 1865-1875.
15	MOR D E, SOHRABI S, KALETSKY R, et al. Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria[J]. Proc Natl Acad Sci USA, 2020, 117(42): 26438-26447.
16	ZU T, GUO S, BARDHI O, et al. Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice[J]. Proc Natl Acad Sci USA, 2020, 117(31): 18591-18599.

[1]	Bing-fu SONG, Bin-bin Ding, Xiao-li ZHANG, Li-yun YAO. Observation of therapeutic efficacy of metformin on glucose dysregulation and dyslipidaemia induced by quetiapine in patients with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 776-780.
[2]	Shi-kai GENG, Le ZHANG, Hui-jing WANG, Liang-jing LÜ, Wei-guo WAN, Fang-fang SUN, Shuang YE. Effect of metformin on infection event reduction in patients with systemic lupus erythematosus:a post-hoc analysis of a Met-Lupus Trial [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(4): 473-478.
[3]	LIU Zhe1, WANG Hai-ting1, WANG Hui-jing1, TENG Xiang-yu2, YE Shuang1. A long-term follow-up study after the open-label proof-of-concept trial of metformin in systemic lupus erythematosus [J]. , 2018, 38(10): 1186-.
[4]	SHI Jia-li, ZHANG Lei, QIAO Ying, SHEN Yi-feng, LI Hua-fang. Ameliorative effect of metformin on insulin resistance induced by olanzapine gavage in rats [J]. , 2017, 37(8): 1064-.
[5]	ZHAO Dan-dan, GU Yan-yun, WANG Ji-qiu, HU Chun-xiu, HONG Jie, ZHANG Yi-fei, the SPREAD-DIMCAD study group. Study on the predictive effect of baseline lipid profiles on recurrent cardiovascular events after antidiabetic drugs intervention [J]. , 2017, 37(6): 744-.
[6]	SONG Meng-ge, QIU Yan. Study on the serum irisin level in patients with polycystic ovary syndrome [J]. , 2016, 36(6): 890-.
[7]	MENG Chao， JIN Xian， WANG Xiao-ling， XIA Li， CAI Jun， FANG Ning-yuan. Effects of losartan potassium on myocardial mitochondrial proteins in spontaneously hypertensive rats with left ventricular hypertrophy [J]. , 2016, 36(10): 1425-.
[8]	ZHANG Duo-duo, LI Pai, ZHANG Wei, et al. Effects of metformin on proliferation and inflammatory response of vascular smooth muscle cells induced by TNF-α [J]. , 2014, 34(9): 1343-.
[9]	WANG Yi-wei, ZHENG Lei-zhen. Advances of metformin and treatment of pancreatic cancer [J]. , 2014, 34(11): 1695-.
[10]	CHU Jing-jing, XU Zhe-rong, DING Cheng, et al. Effects of sitagliptin combined with metformin for type 2 diabetes mellitus: a meta-analysis [J]. , 2013, 33(11): 1501-.
[11]	ZHOU Huan, TENG Xiang-yu, LIU Wei. Effect of combined therapy of roglitazone and metformin on hepatic fat content in type 2 diabetic patients with central obesity [J]. , 2010, 30(10): 1263-.